HWG Holdings LP Invests $2.67 Million in Intuitive Surgical, Inc. (NASDAQ:ISRG)

HWG Holdings LP acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 5,386 shares of the medical equipment provider's stock, valued at approximately $2,668,000. Intuitive Surgical makes up 1.2% of HWG Holdings LP's holdings, making the stock its 21st largest position.

Several other hedge funds also recently modified their holdings of ISRG. Atala Financial Inc bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $25,000. Hurley Capital LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $28,000. Parvin Asset Management LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $26,000. BankPlus Trust Department bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $28,000. Finally, Global Financial Private Client LLC grew its stake in shares of Intuitive Surgical by 253.3% during the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after purchasing an additional 38 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Stock Down 0.0%

Shares of NASDAQ ISRG opened at $509.36 on Monday. The company's fifty day moving average is $528.03 and its 200-day moving average is $537.31. The stock has a market cap of $182.56 billion, a price-to-earnings ratio of 74.69, a P/E/G ratio of 5.40 and a beta of 1.67. Intuitive Surgical, Inc. has a twelve month low of $413.82 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same period last year, the business posted $1.50 earnings per share. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling

In related news, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction on Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the sale, the senior vice president now directly owns 907 shares in the company, valued at $510,740.77. This trade represents a 19.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Robert Desantis sold 188 shares of the firm's stock in a transaction on Monday, April 28th. The stock was sold at an average price of $515.91, for a total transaction of $96,991.08. Following the sale, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,695,113.84. The trade was a 3.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 4,998 shares of company stock worth $2,611,577 over the last ninety days. Company insiders own 0.70% of the company's stock.

Analyst Ratings Changes

A number of brokerages have issued reports on ISRG. Barclays reduced their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. Evercore ISI reduced their price objective on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research note on Wednesday, April 23rd. BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the company a "buy" rating in a research note on Monday, April 14th. Royal Bank Of Canada reduced their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Finally, Piper Sandler reduced their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $588.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.